| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | KIN001-260 | GDSC1000 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | Imatinib | GDSC1000 | pan-cancer | AAC | -0.061 | 0.2 |
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |